The
European Commission adopted has
adopted an Implementing Regulation for the management of conflicts of interest
of those involved in joint clinical assessments and joint scientific
consultations under the Health Technology Assessment (HTA) Regulation.
These rules aim to ensure that EU-level assessments of new
health technologies are conducted in an independent, impartial and transparent
manner, free from conflicts of interest. They provide an assessment framework for exclusions from and
limitations to participation in the joint work on HTA, based on the declared
interests. They will
apply to all parties taking part in joint clinical assessments and joint
scientific consultations, including representatives in the Member State
Coordination Group and its subgroups, the appointed assessors, co-assessors and
patients, clinical experts and other relevant experts involved in these joint
procedures.
This is the third of six acts which must be adopted before
12 January 2025, the date of application of the HTA Regulation. The first implementing act was adopted by the European
Commission on 23 May 2024 and the second implementing act on 18 October 2024.
More info. here